# GlaxoSmithKline dba Human Genome Sciences Inc - Inspection Records

Source: https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc

> Inspection records and compliance data for GlaxoSmithKline dba Human Genome Sciences Inc in Rockville, Maryland. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoSmithKline dba Human Genome Sciences Inc
- FEI Number: 3003782237
- City: Rockville
- State: Maryland
- Country Name: United States
- Address Line 1: 9910 Belward Campus Dr
- Zip Code: 20850

## Related Documents

- [483 - GlaxoSmithKline dba Human Genome Sciences Inc - Unknown Date](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/06180595-cb3e-4947-86f4-5a753f6134fb) — source: FDA, date: Invalid Date
- [483 - GlaxoSmithKline dba Human Genome Sciences Inc - 2025-07-31](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/1bd342b5-73d7-4968-9da2-73fae2cb4d50) — source: FDA, date: July 31, 2025
- [FDA Inspection 1277363 - GlaxoSmithKline dba Human Genome Sciences Inc - 2025-07-31](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/301cdf1e-2f97-4a13-9346-d197d273c543) — source: FDA, date: July 31, 2025
- [FDA Inspection 1277363 - GlaxoSmithKline dba Human Genome Sciences Inc - 2025-07-31](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/eada8799-31c2-4b74-ac57-97ea87f50ca2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 31, 2025
- [483 - GlaxoSmithKline dba Human Genome Sciences Inc - 2023-12-11](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/845ffa38-5805-4d93-95b8-ff8e8d207fcf) — source: FDA, date: December 11, 2023
- [FDA Inspection 1226290 - GlaxoSmithKline dba Human Genome Sciences Inc - 2023-12-11](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/bc0ea99b-2d1e-421a-81f4-998e8c743f9b) — source: FDA, date: December 11, 2023
- [EIR - GlaxoSmithKline dba Human Genome Sciences Inc - 2020-06-29](https://www.keypedia.com/records/eir/glaxosmithkline-dba-human-genome-sciences-inc/a65316e7-80de-4417-a6c5-3709514161cc) — source: FDA, date: June 29, 2020
- [483 - GlaxoSmithKline dba Human Genome Sciences Inc - 2019-03-15](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/d826d0ff-2abb-4e17-978e-118bec3fad2e) — source: FDA, date: March 15, 2019
- [FDA Inspection 1068898 - GlaxoSmithKline dba Human Genome Sciences Inc - 2018-08-30](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/703b7ee9-4dc4-4bca-9987-6c8c933aac6e) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2018
- [FDA Inspection 989778 - GlaxoSmithKline dba Human Genome Sciences Inc - 2016-04-11](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/729ddd1e-ba18-4f7b-b9bc-841a45bcd21b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2016
- [FDA Inspection 854065 - GlaxoSmithKline dba Human Genome Sciences Inc - 2013-11-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/fcad030a-10f3-4e6a-9baa-048402dcf430) — classification: No Action Indicated (NAI), source: FDA, date: November 5, 2013
- [483 - GlaxoSmithKline dba Human Genome Sciences Inc - 2013-04-26](https://www.keypedia.com/records/483/glaxosmithkline-dba-human-genome-sciences-inc/928ba880-1b8c-4356-831e-0f16d2c1f4dd) — source: FDA, date: April 26, 2013
- [FDA Inspection 805643 - GlaxoSmithKline dba Human Genome Sciences Inc - 2012-11-02](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/0e9b9b96-3de2-4874-a745-ef767350966b) — classification: No Action Indicated (NAI), source: FDA, date: November 2, 2012
- [FDA Inspection 679484 - GlaxoSmithKline dba Human Genome Sciences Inc - 2010-09-08](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/67e08bed-26e5-4a98-b880-99302e373d44) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2010
- [FDA Inspection 601372 - GlaxoSmithKline dba Human Genome Sciences Inc - 2009-07-31](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-dba-human-genome-sciences-inc/7cee02b6-bda9-461b-8b5f-3f98f09acd1b) — classification: No Action Indicated (NAI), source: FDA, date: July 31, 2009

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Nehal Oumer](https://www.keypedia.com/people/nehal-oumer/cdf81798-6008-4ea1-a1a4-f71520c3a825)
- [Kathy Lea](https://www.keypedia.com/people/kathy-lea/4975e0a1-73fa-48e6-bb62-bcb2ec9371a2)
- [Shadia Zaman](https://www.keypedia.com/people/shadia-zaman/c534a993-7a9b-401e-bfe7-b209a916cf6e)
- [Andrea Siegel](https://www.keypedia.com/people/andrea-siegel/7436ec58-8c64-4ad9-a6cf-7c2039c51447)
- [Anjali Shukla](https://www.keypedia.com/people/anjali-shukla/23e50484-91bf-436f-971e-2efd3c2b3d0a)
- [recipient](https://www.keypedia.com/people/greg-flyte/62dd17a6-f5e8-4364-b80a-e52d9a894a4a)